Patient Centered Research
Most patients with ME/CFS and Fibromyalgia do not have access to a qualified and compassionate diagnosis, much less the first-class care they deserve.
It is our mission to change that.
One of the most meaningful ways to advance our mission is to participate in research.
We are dedicated to:
- identification and diagnosis for all patients
- bringing well-qualified patients into cutting-edge research regardless of where the research is being conducted
- the swift advancement of progress
- first-class standard of care for all those with ME/CFS and FM
Patient participation in research is essential to advancing the science and medicine of ME/CFS and Fibromyalgia.
Our powerful combination of an active and specialized medical center of excellence with an innovative research program allows us to advance research to discover biomarkers. Biomarkers will improve diagnosis and treatment and put us on a pathway to a cure.
The way we do this is by recruiting clinically defined and well-characterized patients and collecting a variety of biological samples and measures. These samples and measures are then provided to the brightest scientists from elite institutions to discover and validate biomarkers. This is the called the BHC Biomarker Research Project.